Peptic Ulcer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
Condition:   Peptic Ulcer Interventions:   Drug: DWP14012 20mg;   Drug: Lansoprazole 15 mg;   Drug: DWP14012 20mg placebo;   Drug: Lansoprazole 15 mg placebo Sponsor:   Daewoong Pharmaceutical Co. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2021 Category: Research Source Type: clinical trials